You can buy or sell Neurocrine and other stocks, options, ETFs, and crypto commission-free!
Neurocrine Biosciences, Inc. operates as a product based bio-pharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. Read More The company product includes INGREZZA. Neurocrine Biosciences was founded by Kevin C. Gorman and Wylie W. Vale on January 1992 and is headquartered in San Diego, CA.
San Diego, California
52 Week High
52 Week Low
Expected Nov 5, After Hours